Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04925921 · ClinicalTrials.gov registry record · NA

AVAVA SR-1 Wrinkles and BPL Study

A NA study, sponsored by AVAVA.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT04925921 is a NA study that has completed, run by AVAVA. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04925921, a NA study, has completed, sponsored by AVAVA.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This study is being conducted to evaluate the safety and efficacy of a laser called the SR-1 Skin Treatment System, or SR-1 Laser, for the treatment of wrinkles and pigmented spots. Participants will be treated with the SR-1 Laser 3 or 4 times with each treatment spaced 4-6 weeks apart. The improvement in wrinkles and pigmented spots will be evaluated 1 and 3 months after the final treatment.

Interventions

  • DEVICE SR-1 Laser

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-05-10
Est. Completion 2022-07-25
Phase NA

Sponsor

AVAVA

4 total trials

What the Registry Record Tells You About NCT04925921

The ClinicalTrials.gov registry entry for NCT04925921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AVAVA, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which SR-1 Laser is the first listed.

NCT04925921 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04925921 about?

NCT04925921 is a clinical study titled "AVAVA SR-1 Wrinkles and BPL Study". This study is being conducted to evaluate the safety and efficacy of a laser called the SR-1 Skin Treatment System, or SR-1 Laser, for the treatment of wrinkles and pigmented spots. Participants will be treated with the SR-1 Laser 3 or 4 times with each treatment spaced 4-6 weeks apart. The improvem...

What is the current status of trial NCT04925921?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-05-10. Estimated completion is 2022-07-25.

What interventions are being tested in trial NCT04925921?

The interventions under investigation include: SR-1 Laser (DEVICE).

Who is sponsoring clinical trial NCT04925921?

This trial is sponsored by AVAVA, which has 4 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.